Who Is the Data Principal Under DPDP Act:
Doctor, Patient, or Both?
One of the most common sources of confusion under the Digital Personal Data Protection Act 2023 is the concept of the data principal. Pharma and healthcare teams often ask a simple but critical question: who exactly is the data principal in our workflows? Is it the doctor, the patient, or both?
The answer has direct consequences for consent collection, data usage, marketing execution, and compliance accountability. Misidentifying the data principal leads to flawed assumptions about whose consent is required, whose rights must be honoured, and where risk truly lies.
This article explains who qualifies as a data principal under DPDP using real pharma and healthcare data scenarios, and how teams must adapt their engagement models accordingly.
What Does Data Principal Mean Under DPDP Act?
Under the DPDP Act, a data principal is the individual to whom the personal data relates.
This definition is straightforward but powerful. If data can identify an individual, that individual is the data principal for that data. The role does not depend on profession, status, or context. It depends solely on whether the data relates to a specific person.
In healthcare and pharma, this definition often applies to more people than teams initially realise.
Why the Data Principal Question Matters in Pharma ?
Pharma organisations process data relating to multiple individuals across different workflows.
Doctor engagement programs process doctor contact details and interaction history. Patient support programs process patient information. Digital platforms collect behavioural data linked to identifiable users.
Each of these individuals may be a data principal under DPDP.
Correctly identifying the data principal determines whose consent is required, whose rights must be enabled, and whose data must be protected.
When the Doctor Is the Data Principal ?
Doctors are data principals when personal data about them is processed.
This includes names, phone numbers, email addresses, clinic locations, specialisation, engagement history, and digital interaction data. Even when data is used for professional communication, it remains personal data if it identifies the doctor as an individual.
In pharma marketing and engagement, doctors are data principals whenever their personal data is used for communication, analytics, or targeting.
This means doctors have the right to give consent, withdraw consent, and exercise their data rights under DPDP.
When the Patient Is the Data Principal ?
Patients are data principals when their personal data is processed.
Patient data includes names, contact details, health information, treatment history, support program participation, and digital engagement data. This data is often more sensitive and carries higher risk if misused.
Pharma companies processing patient data through support programs, digital tools, or analytics must treat patients as data principals and honour their rights accordingly.
When Both Doctor and Patient Are Data Principals ?
In many real-world healthcare workflows, both doctors and patients may be data principals simultaneously.
For example, a patient support program may process patient data while also storing doctor referral information. A digital engagement platform may track interactions from both doctors and patients.
In such cases, consent and data rights must be managed separately for each data principal. Consent from one does not substitute for consent from the other.
This complexity is often underestimated and leads to compliance gaps.
Common Mistake: Assuming Doctor Data Is Exempt
A frequent mistake in pharma marketing is assuming that doctor data is exempt from data principal rights because it is professional data.
DPDP does not recognise this exemption.
If data identifies a doctor as an individual, the doctor is a data principal. Professional context does not remove personal data protection obligations.
This misunderstanding is one of the most common sources of DPDP non-compliance in doctor marketing workflows.
How Data Principal Identification Affects Consent ?
Consent must be obtained from the correct data principal.
If a campaign targets doctors, consent must come from doctors. If a program targets patients, consent must come from patients. If both groups are involved, separate consent mechanisms may be required.
Consent cannot be assumed or transferred across data principals. This requires careful design of consent flows and engagement logic.
This is where DPDP-compliant HCP marketing frameworks become critical, because they ensure that consent is collected and enforced correctly for each data principal.
Data Principal Rights Under DPDP
Data principals have specific rights under DPDP.
These include the right to access information about how their data is used, the right to withdraw consent, and the right to request correction or deletion of data in certain circumstances.
Pharma and healthcare organisations must have mechanisms to respond to these requests promptly and accurately.
Failure to recognise who the data principal is makes it impossible to fulfil these obligations.
Impact on Marketing and Engagement Workflows
Marketing and engagement workflows must be designed with data principal identification in mind.
Segmentation, targeting, and campaign execution must respect whose data is being used. Systems must prevent misuse of data belonging to one principal for purposes intended for another.
This requires tighter controls and clearer data models than many legacy systems currently provide.
Role of CRMs and Digital Platforms
CRMs and digital engagement platforms must support data principal identification.
They must distinguish between doctor data and patient data. They must map consent to the correct individual and purpose. They must enforce data rights across workflows.
Systems that treat all data uniformly without recognising different data principals introduce compliance risk.
Why Misidentifying the Data Principal Increases Risk ?
When the wrong individual is treated as the data principal, consent becomes invalid. Data rights requests may be mishandled. Audit findings become more likely.
In regulated sectors like healthcare, these errors carry reputational and operational consequences beyond financial penalties.
Correct data principal identification is therefore foundational to DPDP compliance.
Preparing Pharma Teams to Handle Multiple Data Principals
Preparation begins with mapping data flows.
Pharma companies should identify which data principals are involved in each workflow. They should design consent mechanisms accordingly. They should train marketing, medical, and digital teams to understand these distinctions.
This cross-functional understanding reduces the likelihood of inadvertent violations.
Frequently Asked Questions on Data Principal Under DPDP
Who is a data principal under DPDP Act?
⌄
A data principal is the individual to whom the personal data relates.
Are doctors considered data principals under DPDP?
⌄
Yes. Doctors are data principals when their personal data is processed.
Are patients always data principals under DPDP?
⌄
Yes. Patients are data principals for their personal data.
Can both doctors and patients be data principals in one program?
⌄
Yes. Many healthcare workflows involve multiple data principals.
Does professional data remove data principal rights?
⌄
No. Professional context does not exempt personal data from DPDP.
Whose consent is required for doctor marketing?
⌄
Consent must be obtained from the doctor as the data principal.
How does DPDP affect patient support programs?
⌄
Patients must be treated as data principals and their rights honoured.
Do CRMs need to distinguish between data principals?
⌄
Yes. Systems must support correct identification and consent enforcement.
Closing Perspective and CTA
Correctly identifying the data principal under DPDP is not a theoretical exercise. It directly determines whose consent is required, whose rights must be respected, and how engagement programs must operate.
For pharma companies, recognising when doctors, patients, or both act as data principals is essential for compliant and sustainable data driven engagement.
If you are assessing how to design DPDP-compliant HCP marketing and healthcare engagement workflows that correctly handle multiple data principals, this page explains how consent-first execution is implemented in practice.